Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN101177398B details a novel purification method for Triflusal, achieving >99.5% purity via alkaline dissolution and THF/cyclohexane recrystallization, ensuring supply chain stability.
Patent CN108558692A reveals mild NHC-catalyzed amide synthesis. Offers high purity, cost reduction in pharmaceutical intermediates manufacturing, and scalable supply chain solutions.
Novel patent CN105131017B offers high-purity antibiotic intermediate synthesis with improved yield and reduced impurities for reliable supply chain partners.
Patent CN112479853B reveals a novel resin-catalyzed route for D-2-chloropropionyl chloride, offering high purity and cost reduction in API manufacturing without rectification towers.
Patent CN105777592B reveals high-yield synthesis for nitro sulphonyl compounds. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN105017181A reveals a cost-effective route for Carfilzomib intermediates. Discover high-purity manufacturing solutions and supply chain advantages for proteasome inhibitors.
Patent CN105039432A details Penicillium biocatalysis for high-purity chiral intermediates. Achieve substantial cost reduction and supply chain reliability.
Patent CN107778241B details a metal-free route for dihydrophenanthridines, offering cost-effective manufacturing and simplified supply chains for pharma intermediates.
Patent CN105177069A details high-yield biocatalysis for chiral intermediates. Offers sustainable manufacturing and supply chain reliability for global pharmaceutical partners.
Patent CN1798726A reveals a mild palladium-catalyzed reductive cyclization for indoles, offering significant cost reduction and supply chain reliability for API intermediates.
Novel patent CN100434429C details a cleaner route for 2-arylimidazo[2,1-a]isoquinoline, offering cost-effective manufacturing and reduced environmental impact for contraceptive drug production.
Patent CN105087668A reveals high-yield biocatalytic route for chiral intermediates. Achieve cost reduction and supply reliability with green manufacturing processes.
Patent CN105039435A details yeast biocatalysis for high-purity chiral intermediates. Achieve significant cost reduction and supply chain reliability with scalable green manufacturing.
Patent CN119120437A reveals high-efficiency enzyme mutants for tyrosine derivatives. Achieves 160g/L concentration and 99.9% purity, offering significant supply chain and cost advantages for manufacturers.
Novel synthesis route for Saxagliptin intermediate CN105037245B. High yield, scalable process for reliable pharmaceutical intermediate supply chain optimization.
Novel organozinc method for PPI zinc salts ensures high purity and scalability for pharmaceutical manufacturing supply chains.
Patent CN105087674A details high-yield biocatalytic synthesis. Offers supply chain stability and cost reduction in chiral intermediate manufacturing for global partners.
Novel preparation method reduces toxic reagents and improves yield for pazopanib manufacturing supply chain efficiency.
Patent CN1197848C reveals a novel Pt/C catalytic hydrogenation route for isoindoline, offering superior purity and yield for reliable pharmaceutical intermediate supply chains.
Novel oxidative cyclization patent CN107805232A enables cost-effective high-purity furan intermediate manufacturing with scalable supply chain reliability for global pharmaceutical partners.